• Selection of Endpoints in Clinical Trials: Trends in European Marketing Authorization Practice in Oncological Indications

    Aug 1, 2019, 00:00

  • A Scoping Review of Investment Cases for Vaccines and Immunization Programs

    Aug 1, 2019, 00:00

  • Incorporating Affordability Concerns Within Cost-Effectiveness Analysis for Health Technology Assessment [Editor's Choice]

    Aug 1, 2019, 00:00

  • Patient-Reported Outcomes in Orphan Drug Labels Approved by the US Food and Drug Administration [Editor's Choice]

    Aug 1, 2019, 00:00

  • An Ethical Analysis of Coverage With Evidence Development [Editor's Choice]

    Aug 1, 2019, 00:00

  • Table of Contents

    Aug 1, 2019, 00:00

  • Implications of Nonmarginal Budgetary Impacts in Health Technology Assessment: A Conceptual Model

    Aug 1, 2019, 00:00

  • Important Considerations in Modeling the Cost-Effectiveness for the First Food and Drug Administration–Approved Gene Therapy and Implications for Future One-Time Therapies

    Aug 1, 2019, 00:00

  • Author Reply

    Aug 1, 2019, 00:00

  • Copyright/Subscription

    Aug 1, 2019, 00:00

  • Per-Prescription Drug Expenditure by Source of Payment and Income Level in the United States, 1997 to 2015 [Editor's Choice]

    Aug 1, 2019, 00:00

  • Normative Profile of Health-Related Quality of Life for Hong Kong General Population Using Preference-Based Instrument EQ-5D-5L

    Aug 1, 2019, 00:00

  • Editorial Board

    Jul 2, 2019, 09:19

  • Time-Driven Activity-Based Costing in Urologic Surgery Cycles of Care

    Jul 1, 2019, 00:00

  • Cost-Effectiveness Analysis of Pertuzumab With Trastuzumab and Chemotherapy Compared to Trastuzumab and Chemotherapy in the Adjuvant Treatment of HER2-Positive Breast Cancer in the United States

    Jul 1, 2019, 00:00

  • Consistency Between Three Different Ways of Administering the Short Form 6 Dimension Version 2

    Jul 1, 2019, 00:00

  • How Prevalent Are Implausible EQ-5D-5L Health States and How Do They Affect Valuation? A Study Combining Quantitative and Qualitative Evidence

    Jul 1, 2019, 00:00

  • Uncertainty and Coverage With Evidence Development: Does Practice Meet Theory? [Editor's Choice]

    Jul 1, 2019, 00:00

  • How Does Option Value Affect the Potential Cost-Effectiveness of a Treatment? The Case of Ipilimumab for Metastatic Melanoma

    Jul 1, 2019, 00:00

  • Impact of Nonrandomized Dropout on Treatment Switching Adjustment in the Relapsing–Remitting Multiple Sclerosis CLARITY Trial and the CLARITY Extension Study

    Jul 1, 2019, 00:00

  • Parent Proxy Discrepancy Groups of Quality of Life in Childhood Epilepsy

    Jul 1, 2019, 00:00

  • Cancer History, Health Insurance Coverage, and Cost-Related Medication Nonadherence and Medication Cost-Coping Strategies in the United States

    Jul 1, 2019, 00:00

  • The Corrective Approach: Policy Implications of Recent Developments in QALY Measurement Based on Prospect Theory

    Jul 1, 2019, 00:00

  • Evolving Use of Real-World Evidence for Devices: Good for Patients, Good for Policy Makers

    Jul 1, 2019, 00:00

  • Machine Learning for Health Services Researchers [Editor's Choice]

    Jul 1, 2019, 00:00

  • Table of Contents

    Jul 1, 2019, 00:00

  • Reconciling the Seemingly Irreconcilable: How Much Are We Spending on Drugs?

    Jul 1, 2019, 00:00

  • A New Method to Determine the Optimal Willingness to Pay in Cost-Effectiveness Analysis

    Jul 1, 2019, 00:00

  • ISPOR, the FDA, and the Evolving Regulatory Science of Medical Device Products

    Jul 1, 2019, 00:00

  • Copyright/Subscription

    Jul 1, 2019, 00:00

  • Cost-Effectiveness of Alemtuzumab in the Treatment of Relapsing Forms of Multiple Sclerosis in the United States

    Jun 1, 2019, 00:00

  • A Beginner's Guide to Understanding Curative Therapies

    Jun 1, 2019, 00:00

  • New Approaches to Value Assessment: Towards More Informed Pricing in Healthcare—An Introduction

    Jun 1, 2019, 00:00

  • Analytic Considerations in Applying a General Economic Evaluation Reference Case to Gene Therapy [Editor's Choice]

    Jun 1, 2019, 00:00

  • Meaningful and Measurable Health Domains in Huntington’s Disease: Large-Scale Validation of the Huntington’s Disease Health-Related Quality of Life Questionnaire Across Severity Stages

    Jun 1, 2019, 00:00

  • Defining and Managing High-Priced Cures: Healthcare Payers’ Opinions

    Jun 1, 2019, 00:00

  • Effect of Health State Sampling Methods on Model Predictions of EQ-5D-5L Values: Small Designs Can Suffice

    Jun 1, 2019, 00:00

  • Table of Contents

    Jun 1, 2019, 00:00

  • Patient Preferences for Endometriosis Pain Treatments in the United States

    Jun 1, 2019, 00:00

  • Development and Validation of the MiPrep Survey: An Instrument Assessing Patients' Perceived Preparation for Medical Interventions Including Medical Imaging, Radiotherapy, and Surgery

    Jun 1, 2019, 00:00

  • Uncertainty and Cures: Discontinuation, Irreversibility, and Outcomes-Based Payments: What Is Different About a One-Off Treatment?

    Jun 1, 2019, 00:00

  • Current Value Frameworks—What's New?

    Jun 1, 2019, 00:00

  • A Cost-Effectiveness Analysis of Shortened Direct-Acting Antiviral Treatment in Genotype 1 Noncirrhotic Treatment-Naive Patients With Chronic Hepatitis C Virus

    Jun 1, 2019, 00:00

  • Valuing Health Status in the First Year of Life: The Infant Health-Related Quality of Life Instrument

    Jun 1, 2019, 00:00

  • Current Policy and Practice for Value-Based Pricing

    Jun 1, 2019, 00:00

  • Real-World Evidence in Healthcare Decision Making: Global Trends and Case Studies From Latin America

    Jun 1, 2019, 00:00

  • Estimating the Clinical Pipeline of Cell and Gene Therapies and Their Potential Economic Impact on the US Healthcare System [Editor's Choice]

    Jun 1, 2019, 00:00

  • Specific Value Assessment Considerations

    Jun 1, 2019, 00:00

  • Copyright/Subscription

    Jun 1, 2019, 00:00

  • Are Global Health Systems Ready for Transformative Therapies?

    Jun 1, 2019, 00:00

  • Are Payers Ready, Willing, and Able to Provide Access to New Durable Gene Therapies? [Editor's Choice]

    Jun 1, 2019, 00:00

  • Novel Approaches to Value Assessment Within the Cost-Effectiveness Framework

    Jun 1, 2019, 00:00

  • Guide for Authors

    Jun 1, 2019, 00:00

  • Editorial Board

    Jun 1, 2019, 00:00

  • New Cost-Effectiveness Methods to Determine Value-Based Prices for Potential Cures: What Are the Options? [Editor's Choice]

    Jun 1, 2019, 00:00

  • How Does Treating Chronic Hepatitis C Affect Individuals in Need of Organ Transplants in the United Kingdom?

    Jun 1, 2019, 00:00

  • Novel Approaches to Value Assessment Beyond the Cost-Effectiveness Framework

    Jun 1, 2019, 00:00

  • Practical Next Steps in Improving Value Measurement and Use

    Jun 1, 2019, 00:00

  • Comparing the Noncomparable: The Need for Equivalence Measures That Make Sense in Health-Economic Evaluations [Editor's Choice]

    Jun 1, 2019, 00:00

  • Editorial Board

    May 17, 2019, 08:37

  • Diabetes/Endocrine/Metabolic Disorders - Methodological Statistical Research

    May 1, 2019, 00:00

  • PNS115 ASSOCIATION BETWEEN THE AFFORDABLE CARE ACT (ACA) AND REDUCED DISPARITIES IN ACCESS TO CARE BY ENGLISH LANGUAGE PROFICIENCY AMONG HISPANIC ADULTS

    May 1, 2019, 00:00

  • Musculoskeletal Disorders - Epidemiology Public Health

    May 1, 2019, 00:00

  • PDG20 COST-EFFECTIVENESS ANALYSIS OF EZETIMIBE AS THE ADD-ON TREATMENT TO MODERATE-DOSE ROSUVASTATIN VERSUS HIGH-DOSE ROSUVASTATIN IN THE SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES IN CHINA: A MARKOV MODEL ANALYSIS BASED ON NSTE-ACS

    May 1, 2019, 00:00

  • PMD30 HOSPITAL RELATED CLINICAL AND ECONOMICAL OUTCOMES OF TWO PREMIUM KNEE SYSTEM IN TOTAL KNEE ARTHROPLASTY PATIENTS

    May 1, 2019, 00:00

  • PNS158 ARE THE PRIMARY HEALTH CENTERS ADEQUATELY EQUIPPED TO DELIVER PRIMARY HEALTHCARE IN INDIA? A STUDY OF PUBLIC HEALTH MANPOWER AND INFRASTRUCTURE

    May 1, 2019, 00:00

  • PIH19 A SYSTEMATIC REVIEW OF PHARMACOECONOMIC LITERATURE SCORING TOOLS FOR STUDIES ON HORMONAL CONTRACEPTIVES

    May 1, 2019, 00:00

  • PMH38 INCREASING PREVALENCE OF DEPRESSION AND THE ASSOCIATED RISK FACTORS IN THE US: A STUDY BASED ON NHANES FROM 2005 TO 2016

    May 1, 2019, 00:00

  • Injury Trauma - Clinical Outcomes

    May 1, 2019, 00:00

  • PCN270 DEVELOPING A PATIENT-REPORTED OUTCOME MEASURE TO CAPTURE ADVERSE EVENTS IN PATIENTS WITH NON-SMALL CELL LUNG CANCER

    May 1, 2019, 00:00

  • PNS19 AN APPROACH TO EXAMINING GEOGRAPHIC VARIATION IN HEALTHCARE SPENDING AND UTILIZATION IN THE CANADIAN WORKERS COMPENSATION SYSTEM

    May 1, 2019, 00:00

  • NO Specific Disease - Conceptual Papers (CP)

    May 1, 2019, 00:00

  • PCN281 KNOWLEDGE OF PALLIATIVE CARE AMONG AMERICAN ADULTS: 2018 HEALTH INFORMATION NATIONAL TRENDS SURVEY

    May 1, 2019, 00:00

  • PIN36 A COST CONSEQUENCE MODEL TO EVALUATE THE IMPACT OF BLOOD CULTURE TECHNOLOGY AND BEST PRACTICES ON SEPSIS MANAGEMENT

    May 1, 2019, 00:00

  • PND75 PROMIS-PREFERENCE SCORES ARE ASSOCIATED WITH UTILIZATION IN OUTPATIENT NEUROLOGY PATIENTS

    May 1, 2019, 00:00

  • PDG22 A DECISION ANALYSIS OF ADDING ANGIOTENSIN II TO RENAL REPLACEMENT THERAPY TO TREAT PATIENTS WITH ACUTE KIDNEY INJURY AND VASODILATORY SHOCK

    May 1, 2019, 00:00

  • Drugs Process of Care

    May 1, 2019, 00:00

  • PNS223 A BIBLIOMETRICS ANALYSIS OF COST-CONSEQUENCE ANALYSIS USED IN ECONOMICAL EVALUATIONS

    May 1, 2019, 00:00

  • Injury Statistical Research

    May 1, 2019, 00:00

  • PDG55 INDEX OF INSTABILITY OF THE DEMAND OF TECHNOLOGIES IN RELEVANT MARKETS OF CONTRACEPTIVES

    May 1, 2019, 00:00

  • PNS2 APPLICATION OF MACHINE LEARNING TECHNIQUES IN OUTCOMES RESEARCH: A REVIEW

    May 1, 2019, 00:00

  • PIH35 ECONOMIC BURDEN FOR PEDIATRIC PATIENTS WITH RELAPSED B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) IN THE US

    May 1, 2019, 00:00

  • PMD34 COMPARISON OF MEDICAL RESOURCE UTILIZATION AND COSTS BETWEEN PATIENTS WITH EARLY POSTOPERATIVE PERIPROSTHETIC HIP FRACTURES AND THOSE WITHOUT FOLLOWING TOTAL HIP ARTHROPLASTY: A MULTILEVEL MATCHED ANALYSIS

    May 1, 2019, 00:00

  • PNS193 MODELING ADOPTION AND OPTIMIZATION OF AUTOMATION SUPPLY CHAIN MANAGEMENT TECHNOLOGY WITH RFID (UHF) IN THE US ACUTE HOSPITAL SETTING

    May 1, 2019, 00:00

  • PND90 REAL WORLD REPLICATION OF CLINICAL TRIAL FINDINGS IN ALZHEIMER'S DISEASE

    May 1, 2019, 00:00

  • PCN292 STUDY ON PHYSICIANS' PREFERENCE FOR TREATMENT OF NSCLC IN WESTERN CHINA

    May 1, 2019, 00:00

  • PCN238 CANCER PATIENT ENGAGEMENT IN 2018 - COMMUNITY PROVIDERS PERSPECTIVES ON DIGITAL DATA AND COMMUNICATION AT THE BEDSIDE

    May 1, 2019, 00:00

  • PDB9 FACTORS ASSOCIATED WITH AND IMPLICATIONS OF MEETING OR NOT MEETING HBA1C TARGETS IN TYPE 2 DIABETES MELLITUS

    May 1, 2019, 00:00

  • Diabetes/Endocrine/Metabolic Disorders - Conceptual Papers (CP)

    May 1, 2019, 00:00

  • PND56 USE OF IPRATROPIUM AND SALMETEROL MIGHT REDUCE THE RISK OF MULTIPLE SCLEROSIS (MS)

    May 1, 2019, 00:00

  • PNS178 CONSUMER HEALTH INFORMATION TECHNOLOGY IN THE PREVENTION OF SUBSTANCE ABUSE: A SCOPING REVIEW

    May 1, 2019, 00:00

  • Table of Contents

    May 1, 2019, 00:00

  • PND50 PRESCRIPTION PATTERN OF ANTICHOLINERGIC DRUGS IN ALZHEIMER'S DISEASE

    May 1, 2019, 00:00

  • PMU19 EVALUATION OF THE COSTS OF A COMPREHENSIVE ONE HEALTH PREPAREDNESS INTERVENTION PROGRAM IN 3 DISTRICTS IN UGANDA'S WEST NILE REGION

    May 1, 2019, 00:00

  • PMU113 THE COST OF MEDICAL TELECONSULTATIONS OF A BRAZILIAN GOVERNMENT EHEALTH SERVICE

    May 1, 2019, 00:00

  • PMH62 AN ASSESSMENT OF THE HUMANISTIC IMPACT OF SCHIZOPHRENIA IN RELATION TO CAREGIVER AND PRODUCTIVITY BURDEN

    May 1, 2019, 00:00

  • PNS30 CAN AYUSHMANN BHARAT ALTER INDIA'S HEALTHCARE LANDSCAPE?

    May 1, 2019, 00:00

  • PND16 A RETROSPECTIVE CLAIMS ANALYSIS OF US HEALTH PLAN COMMERCIAL INSURANCE DATA ASSESSING HEALTHCARE COSTS AND RELAPSE RATES IN MULTIPLE SCLEROSIS PATIENTS TREATED WITH GENERIC GLATIRAMER ACETATE

    May 1, 2019, 00:00

  • PIH31 COST-EFFECTIVENESS ANALYSIS OF REGORAFENIB AS A SECOND-LINE THERAPY IN THE TREATMENT OF HEPATOCELLULAR CARCINOMA IN CHINA

    May 1, 2019, 00:00

  • PCN301 DEVELOPMENT OF PLAYBOOK FOR CHART REVIEW IN REAL WORLD DATA

    May 1, 2019, 00:00

  • PCV41 HEALTHCARE RESOURCE UTILIZATION AND ACUTE COSTS IN FRENCH PATIENTS WITH CORONARY ARTERY DISEASE AND PERIPHERAL ARTERY DISEASE

    May 1, 2019, 00:00

  • PNS9 PROPENSITY SCORE MATCHING AND REWEIGHTING TO ASSESS COMPARATIVE EFFICACY OF SINGLE-ARM TRIALS: A GENERAL FRAMEWORK AND SIMULATION STUDY

    May 1, 2019, 00:00

  • PNS171 MAKING OUTCOMES DATA FROM SYSTEMATIC REVIEWS ACCESSIBLE – THE SYSTEMATIC REVIEW DATA REPOSITORY 2.0

    May 1, 2019, 00:00

  • PNS49 WHAT'S TRENDING? PHARMACOECONOMIC PUBLICATIONS IN THE US BETWEEN 2009–2018

    May 1, 2019, 00:00

  • PPM4 COST-EFFECTIVENESS ANALYSIS OF NEXT GENERATION SEQUENCING PANEL OF CIRCULATING TUMOR DNA IN THE DIAGNOSIS OF PATIENT WITH METASTATIC NON-SQUAMOUS NON- SMALL CELL LUNG CANCER IN BRAZIL

    May 1, 2019, 00:00

  • PDB121 EVALUATING INTERVENTION TRAJECTORIES OF STATIN ADHERENCE FOLLOWING A MOTIVATIONAL-INTERVIEWING INTERVENTION CUSTOMIZED BY PAST ADHERENCE TRAJECTORIES TO IMPROVE STATIN ADHERENCE

    May 1, 2019, 00:00

  • PCV79 IS THERE A CHANNELING BIAS IN ABLATION FOR ATRIAL FIBRILLATION? A TALE OF TWO TECHNOLOGIES

    May 1, 2019, 00:00

  • PNS231 THE VALUE OF EMBEDDED INTERVIEWS: CASE STUDY OF QUALITATIVE AND QUANTITATIVE ASSESSMENT OF THE PATIENT EXPERIENCE OF MEPOLIZUMAB SELF-ADMINISTRATION

    May 1, 2019, 00:00

  • PND65 OPIOID AND OTHER ACUTE MEDICATION UTILIZATION AMONGST MIGRAINEURS IN AN EMPLOYED POPULATION

    May 1, 2019, 00:00

  • PIN30 IMPACT OF DISEASE SEVERITY ON HEALTHCARE COSTS IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION (HCV)

    May 1, 2019, 00:00

  • PNS191 A COMPARISON OF HIGH-DIMENSIONAL PROPENSITY SCORE AND TRADITIONAL PROPENSITY SCORE MATCHING METHODS USING COMMERCIAL HEALTH CARE CLAIMS DATA

    May 1, 2019, 00:00

  • PIT8 COST-EFFECTIVENESS ANALYSIS OF PHYSICAL THERAPY AGAINST CHIROPRACTIC FOR PATIENTS WITH ACUTE LOW BACK PAIN IN THE US

    May 1, 2019, 00:00

  • Diabetes/Endocrine/Metabolic Disorders - Medical Technologies

    May 1, 2019, 00:00

  • PIH24 COST OF TREATING IRON DEFICIENCY ANAEMIA (IDA) WITH FERRIC CARBOXYMALTOSE VERSUS IRON SACCHARATE IN HEAVY UTERINE BLEEDING (HUB) PATIENTS IN THE KINGDOM OF SAUDI ARABIA

    May 1, 2019, 00:00

  • PMU62 US CARE PATHWAYS: CONTINUED FOCUS ON ONCOLOGY AND OUTSTANDING CHALLENGES

    May 1, 2019, 00:00

  • Cancer - Methodological Statistical Research

    May 1, 2019, 00:00

  • PNS133 POLICIES TO IMPROVE AMR PRACTICES: AN INDUSTRY AND HCP PERSPECTIVE

    May 1, 2019, 00:00

  • PIH53 PATTERNS AND PREDICTORS OF OFF-LABEL ANTIPSYCHOTIC USE AMONG OLDER ADULTS WITH DEMENTIA IN AMBULATORY CARE SETTINGS IN THE UNITED STATES (US)

    May 1, 2019, 00:00

  • PNS105 AN EVALUATION OF MARKET-ENTRY PRICES FOR NEW MOLECULAR ENTITIES IN THE US FROM 2000 TO 2017

    May 1, 2019, 00:00

  • PNS259 PARTICIPANT ENGAGEMENT IN REAL WORLD LONGITUDINAL RESEARCH STUDIES

    May 1, 2019, 00:00

  • PIH48 A RETROSPECTIVE DATABASE ANALYSIS OF SHORT-ACTING AND LONG-ACTING OPIOID USE IN WOMEN WITH ENDOMETRIOSIS: II-PATTERNS OF UTILIZATION

    May 1, 2019, 00:00

  • PNS33 BUGSNET: A NEW COMPREHENSIVE R PACKAGE FOR NETWORK META-ANALYSIS

    May 1, 2019, 00:00

  • PMU93 MODELING YEARS OF LIFE SAVED IN JAPAN, ITALY, SINGAPORE, AND U.S. BY INTRODUCING A REDUCED-RISK TOBACCO PRODUCT

    May 1, 2019, 00:00

  • PDB64 ASSOCIATION BETWEEN CARDIOVASCULAR DISEASE RISK FACTORS AND HYPOGLYCAEMIC EVENTS IN TYPE 2 DIABETES USING THE IQVIA CORE DIABETES MODEL

    May 1, 2019, 00:00

  • PDB113 EVOLVING OUR UNDERSTANDING OF THE PATIENT EXPERIENCE OF HYPOGLYCEMIC EVENTS

    May 1, 2019, 00:00

  • PNS135 ATTITUDES TOWARD DRUG PRICING IN THE US: FINDINGS FROM A SURVEY IN THE GENERAL POPULATION

    May 1, 2019, 00:00

  • PMS40 EVALUATING REAL-WORLD DISCHARGE READINESS AND LENGTH OF STAY (LOS) FOR TOTAL KNEE ARTHROPLASTY (TKA) IN AUSTRALIA

    May 1, 2019, 00:00

  • Neurological Disorders - Methodological Statistical Research

    May 1, 2019, 00:00

  • PMU48 THE AFFORDABLE CARE ACT AND OUTBOUND MEDICAL TRAVEL FROM THE UNITED STATES

    May 1, 2019, 00:00

  • PMD11 TOTAL HIP REPLACEMENT: RISK AND BURDEN OF POST-SURGICAL DEEP AND SUPERFICIAL INFECTION

    May 1, 2019, 00:00

  • PNS120 RECENT PRICE NEGOTIATIONS ON INNOVATIVE MEDICINES IN CHINA: INFLUENCING FACTORS AND IMPLICATIONS

    May 1, 2019, 00:00

  • PCN241 USING TIME SERIES ANALYSIS TO FORECAST THE HEALTH-RELATED QUALITY OF LIFE OF POST-MENOPAUSAL WOMEN WITH NON-METASTATIC ER+ BREAST CANCER: A TUTORIAL AND CASE STUDY

    May 1, 2019, 00:00

  • PIH64 FACTORS ASSOCIATED WITH QUALITY OF LIFE AMONG OLDER PEOPLE LIVING WITH HIV

    May 1, 2019, 00:00

  • PNS74 GENDER DIFFERENCES IN THE ASSOCIATION OF CURRENT SMOKING WITH SOCIOECONOMIC FACTORS IN A REPRESENTATIVE JAPANESE POPULATION

    May 1, 2019, 00:00

  • PMU44 FOODBORNE ILLNESSES AND CHRONIC SEQUELAE: A REVIEW OF DISEASE BURDEN EVALUATIONS

    May 1, 2019, 00:00

  • PCV6 POST-ABLATION EARLY SYMPTOMATIC RECURRENCE PREDICTS LATE SYMPTOMATIC RECURRENCE OF ATRIAL FIBRILLATION (AFIB): FINDINGS FROM A LARGE STUDY IN REAL-WORLD SETTINGS

    May 1, 2019, 00:00

  • PMS27 COSTS AND DISEASE ACTIVITY IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH BIOLOGIC DMARDS: FINDINGS IN A REAL-LIFE SETTING

    May 1, 2019, 00:00

  • PCV48 THE INFLUENCE OF THE SOCIO-ECONOMIC STATUS IN THE DISEASE BURDEN OF CARDIOVASCULAR DISEASES IN THE UNITED STATES

    May 1, 2019, 00:00

  • PCN313 A RETROSPECTIVE OBSERVATIONAL STUDY ON CHARACTERISTICS AND MEDICAL RESOURCE UTILIZATION OF CANCER PATIENTS IN CHINA

    May 1, 2019, 00:00

  • PDB15 EFFICACY AND SAFETY OF ONCE-DAILY ERTUGLIFLOZIN COMPARED WITH CONTROL THERAPY IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: A SYSTEMATIC LITERATURE REVIEW AND META-ANALYSIS

    May 1, 2019, 00:00

  • PIH25 HEALTHCARE RESOURCE UTILIZATION AND DIRECT HEALTHCARE COST RELATED TO PEANUT ALLERGY IN PEDIATRIC MEDICAID PATIENTS

    May 1, 2019, 00:00

  • PDB80 WHICH OUTCOME QUALITY MEASURES DO LEADING KOLS WHO TREAT NONALCOHOLIC STEATOHEPATITIS (NASH) RECOMMEND FOR VALUE-BASED CONTRACTING ACROSS MULTIPLE STAKEHOLDERS?

    May 1, 2019, 00:00

  • PCV112 ISCHEMIC STROKE IN KOREA; ESTIMATION OF LIFETIME RISK, LIFE EXPECTANCY, QUALITY-ADJUSTED LIFE EXPECTANCY AND LIFETIME COST

    May 1, 2019, 00:00

  • PIN73 ESTIMATIVE OF HIGH RISK PATIENTS FOR PNEUMOCOCCAL DISEASE ON NATIONAL IMUNIZATION PROGRAM IN BRAZIL

    May 1, 2019, 00:00

  • PDG3 USING RWD TO EXAMINE THE ASSOCIATION BETWEEN FLUOROQUINOLONE USE AND AORTIC ANEURYSM (AA)

    May 1, 2019, 00:00

  • PMU79 ASSOCIATION BETWEEN PERCEIVED RISK AND WILLINGNESS TO PAY THRESHOLDS AMONG INTERVENTIONS FOR COMMON DISEASES

    May 1, 2019, 00:00

  • PCV76 EFFECTS OF AGE ON THE ASSOCIATION BETWEEN COMORBIDITIES AND MORTALITY IN ADULTS WITH HEART FAILURE

    May 1, 2019, 00:00

  • Neurological Disorders - Health Service Delivery Process of Care

    May 1, 2019, 00:00

  • PMU9 DO NICE APPRAISAL PROCESSES REWARD INNOVATIVE AND CURATIVE THERAPIES? AN ASSESSMENT OF CURRENT AND POTENTIAL FUTURE TECHNOLOGY APPRAISALS FOR RARE DISEASES

    May 1, 2019, 00:00

  • PIT24 RETROSPECTIVE ANALYSIS OF NEGATIVE PRESSURE USAGE IN HOSPITALS

    May 1, 2019, 00:00

  • PCN245 APPLICABILITY OF A RESPONSE-BASED MODEL IN NEWLY-DIAGNOSED TRANSPLANT-INELIGIBLE MULTIPLE MYELOMA

    May 1, 2019, 00:00

  • PND69 MIGRAINE PROPHYLAXIS WITH VITAMINS AND MINERALS: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS

    May 1, 2019, 00:00

  • PCV15 SWITCHING VS. CONTINUING APIXABAN TREATMENT IS ASSOCIATED WITH A GREATER RISK FOR MAJOR BLEEDING-RELATED HOSPITALIZATION IN ELDERLY PATIENTS WITH NVAF

    May 1, 2019, 00:00

  • PND44 EPIDEMIOLOGY AND DETERMINANTS OF CHRONIC MIGRAINE: A REAL-WORLD STUDY IN PRIMARY CARE IN ITALY

    May 1, 2019, 00:00

  • PDB131 INSULIN TREATMENT PATTERN, RESOURCE UTILIZATION AND COSTS IN CHINESE PATIENTS WITH TYPE 2 DIABETES MELLITUS INITIATED BASAL OR PREMIXED INSULIN ANALOGS AFTER INSULIN INTENSIFICATION

    May 1, 2019, 00:00

  • PMU106 EVALUATING THE ABILITY OF A MOBILE MEDICATION APP TO IMPROVE ADHERENCE IN A CHRONICALLY NON-ADHERENT POPULATION IN HYPERTENSION, DIABETES AND DEPRESSION

    May 1, 2019, 00:00

  • PNS17 RECENT TRENDS AND EVOLUTION OF RISK SHARING AGREEMENTS FROM 2017 TO 2019 IN THE UNITED STATES

    May 1, 2019, 00:00

  • PNS92 INDICATION-SPECIFIC PRICING: HOW DO PAYERS MANAGE DRUGS WITH MULTIPLE INDICATIONS?

    May 1, 2019, 00:00

  • PNS130 CORRELATION BETWEEN HOFSTEDE'S MODEL OF NATIONAL CULTURE AND HEALTHCARE MODELS OF REPRESENTATIVE COUNTRIES: UNITED STATES OF AMERICA, GERMANY, UNITED KINGDOM AND CROATIA

    May 1, 2019, 00:00

  • PMU56 PROPOSED CHANGES TO MEDICARE PART D: WILL PROTECTED CLASSES BECOME A LITTLE LESS PROTECTED TO LOWER DRUG PRICES?

    May 1, 2019, 00:00

  • PCV63 IMPACT OF DEPRESSION ON HEALTH-RELATED QUALITY OF LIFE AMONG OLDER ADULTS WITH MYOCARDIAL INFARCTION IN THE UNITED STATES

    May 1, 2019, 00:00

  • PNS205 GENERATING A REALISTIC SIMULATED ADMINISTRATIVE CLAIMS DATASET FOR DRUG SAFETY AND EFFECTIVENESS RESEARCH AND TRAINING

    May 1, 2019, 00:00

  • PCN252 QUALITY EVALUATION OF PHARMACOECONOMIC STUDIES IN RUSSIAN CANCER RESEARCH: AN OUTSIDE VIEW

    May 1, 2019, 00:00

  • PND84 FACTORS THAT IMPACT HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH TARDIVE DYSKINESIA: REGRESSION ANALYSES OF DATA FROM THE REAL-WORLD RE-KINECT STUDY

    May 1, 2019, 00:00

  • PDB78 PREVALENCE OF FAMILIAL HYPERLIPIDEMIA IN THE ADULT POPULATION OF THE COLOMBIAN CARIBBEAN

    May 1, 2019, 00:00

  • Infectious Diseases - Health Technology Assessment

    May 1, 2019, 00:00

  • PMH17 ANTIPSYCHOTIC POLYPHARMACY: PREDICTORS AND HEALTH CARE COSTS AMONG INSURED PATIENTS IN THE US

    May 1, 2019, 00:00

  • PDG51 EVALUATING GENDER DIFFERENCES IN PRESCRIBING PATTERNS OF OPIOID MEDICATIONS IN THE U.S. FROM 2006-2015

    May 1, 2019, 00:00

  • PCV47 MODELING THE MORTALITY IMPACT OF BUDGET THRESHOLDS

    May 1, 2019, 00:00

  • PMS8 CLINICAL AND COST EFFECTIVENESS OF PHYSIOTHERAPY INTERVENTIONS FOLLOWING HIP REPLACEMENT- A SYSTEMATIC REVIEW

    May 1, 2019, 00:00

  • PDG33 THE EFFECT OF MISSING A SPECIALTY MEDICATION DOSE ON TOTAL HEALTHCARE COST BURDEN

    May 1, 2019, 00:00

  • PNS264 AUTOMATED GENERATION OF EVIDENCE-GAP MAPS FROM MEDICAL LITERATURE

    May 1, 2019, 00:00

  • Mental Health - Epidemiology Public Health

    May 1, 2019, 00:00

  • PDB74 COMPARISON OF HEALTHCARE RESOURCE USE AND COSTS BETWEEN PATIENTS WITH DIAGNOSED HOMOCYSTINURIA AND PHENYLKETONURIA IN THE UNITED STATES

    May 1, 2019, 00:00

  • PNS127 SECTOR-NEUTRAL REIMBURSEMENT OF HEALTH CARE SERVICES IN HUNGARY

    May 1, 2019, 00:00

  • Personalized Statistical Research

    May 1, 2019, 00:00

  • PNS229 AN EVALUATION OF A PHARMACY-LED MEDICATION MANAGEMENT PROGRAM TO IMPROVE PHARMACY PERFORMANCE

    May 1, 2019, 00:00

  • PIT11 ANNUAL ECONOMIC BURDEN OF ADVERSE CHILDHOOD EXPERIENCES IN THE UNITED STATES

    May 1, 2019, 00:00

  • Gastrointestinal Disorders - Clinical Outcomes

    May 1, 2019, 00:00

  • Valuing Health: Evolution, Revolution, Resistance, and Reform

    May 1, 2019, 00:00

  • PNS143 PREFERENCES IN THE PRESCRIPTION OF INSULINS IN PATIENTS WITH TYPE II DIABETES MELLITUS IN COLOMBIA

    May 1, 2019, 00:00

  • PND3 HEALTH OUTCOMES ASSOCIATED WITH ADHERENCE TO HEALTHCARE EFFECTIVENESS DATA AND INFORMATION SET (HEDIS) ANTIDEPRESSANT MEDICATION MANAGEMENT MEASURES DURING ACUTE AND CONTINUATION PHASES OF DEPRESSION TREATMENT AMONG OLDER ADULTS WITH D ...

    May 1, 2019, 00:00

  • PDG24 IMPACT OF BYPASSING MEDICATION DEDUCTIBLES AMONG MEMBERS ENROLLED IN HIGH DEDUCTIBLE HEALTH PLANS

    May 1, 2019, 00:00

  • Medical Devices - Epidemiology Public Health

    May 1, 2019, 00:00

  • PND21 10-YEAR COST-EFFECTIVENESS ANALYSES OF FREMANEZUMAB AS PREVENTIVE TREATMENT IN CHRONIC AND EPISODIC MIGRAINE

    May 1, 2019, 00:00

  • PDB130 RISK EQUATIONS FOR COMPLICATIONS OF TYPE2 DIABETES USING REAL-WORLD ELECTRONIC MEDICAL RECORDS: LOCALIZED VS. GENERALIZABLE

    May 1, 2019, 00:00

  • PNS164 VALUATION OF PREDICTIVE MODELS IN HEALTHCARE: A REVIEW OF UTILITY METHODS

    May 1, 2019, 00:00

  • PGI2 USE OF DIFFERENT STATISTICAL APPROACHES TO COMPARE REAL-WORLD OUTCOMES ASSOCIATED WITH VEDOLIZUMAB VERSUS INFLIXIMAB IN BIOLOGIC-NAIVE PATIENTS WITH INFLAMMATORY BOWEL DISEASE

    May 1, 2019, 00:00

  • PIH21 COST SUBSTITUTION IMPACT ANALYSIS OF HIGH PURITY HUMAN URINARY FOLLICLE STIMULATING HORMONE FOR THE CONTROLLED OVARIAN STIMULATION IN IN-VITRO FERTILIZATION IN CHINA

    May 1, 2019, 00:00

  • Drugs Regulatory

    May 1, 2019, 00:00

  • PCV33 HEALTH INSURANCE COST OF VENOUS EMBOLISM AND THROMBOSIS IN HUNGARY: COST OF ILLNESS STUDY BASED ON NATIONWIDE, REAL WORLD DATA

    May 1, 2019, 00:00

  • PND11 HEALTHCARE RESOURCE UTILIZATION AND CLINICAL OUTCOMES IN HOSPITALIZED PATIENTS WITH HEPATIC ENCEPHALOPATHY IN THE UNITED STATES: A NATIONWIDE STUDY

    May 1, 2019, 00:00

  • PNS244 ASSOCIATION BETWEEN SELF-REPORTED CANNABIS USE AND SLEEP PROBLEMS: THE ARKANSAS MEDICAL CANNABIS STUDY

    May 1, 2019, 00:00

  • PNS37 BUDGET IMPACT ANALYSIS OF ANTIMICROBIAL SUTURES: A US HOSPITAL PERSPECTIVE

    May 1, 2019, 00:00

  • PMU65 ANALYSIS OF THE EARLY PERFORMANCE OF INTEGRATED CARE SYSTEMS IN THE UK USING A DIFFERENCE-IN-DIFFERENCES APPROACH

    May 1, 2019, 00:00

  • PDB39 THE BURDEN OF HYPOGLYCEMIC EVENTS DURING AN INPATIENT HOSPITAL STAY IN PATIENTS WITH DIABETES USING INSULIN: A U.S. RETROSPECTIVE DATABASE ANALYSIS

    May 1, 2019, 00:00

  • PNS245 DEVELOPING PRIORITIES FOR THE COMMUNITY ENGAGEMENT TRAINING OF HEALTHCARE PROFESSIONAL STUDENTS

    May 1, 2019, 00:00

  • Future of Patients in Healthcare Evaluation: The Patient-Informed Reference Case

    May 1, 2019, 00:00

  • Multiple Diseases - Economic Evaluation

    May 1, 2019, 00:00

  • PPM3 COST-EFFECTIVENESS OF SCREENING AND MANAGEMENT STRATEGIES FOR FAMILIAL HYPERCHOLESTEROLEMIA IN THE UNITED STATES: AN UPDATE

    May 1, 2019, 00:00

  • PMU2 THE ROLE OF TREATMENT EXPECTANCY ON THE PLACEBO RESPONSE AS IT PERTAINS TO THE DEVELOPMENT AND IMPLEMENTATION OF PATIENT-REPORTED OUTCOME MEASURES

    May 1, 2019, 00:00

  • PNS83 EXAMINING THE TEMPORAL IMPACT OF THE CMS SUNSHINE ACT ON THE INDUSTRY-PHYSICIAN RELATIONSHIP: AN UPDATED ANALYSIS

    May 1, 2019, 00:00

  • PNS80 DEREGULATION AND ACCESS TO MEDICINES: THE CASE OF CHINA

    May 1, 2019, 00:00

  • PDB10 PROGRESSION FROM METABOLIC SYNDROME TO NON-ALCOHOLIC FATTY LIVER DISEASE: ANALYSES IN AN EMR-CLAIMS DATABASE

    May 1, 2019, 00:00

  • PND77 A SYSTEMATIC LITERATURE REVIEW OF PATIENT REPORTED OUTCOME MEASURES IN SHARED DECISION MAKING FOR PARKINSON'S DISEASE

    May 1, 2019, 00:00

  • PIN32 DISEASE AND ECONOMIC BURDEN COST OF DENGUE ILLNESS IN INDIA: AN UPDATE FROM 2013 TO 2017

    May 1, 2019, 00:00

  • PIH28 COST-EFFECTIVENESS OF INHALED NITRIC OXIDE FOR TREATMENT OF INFANTS WITH HYPOXIC RESPIRATORY FAILURE: ADMINISTRATION AT HOSPITAL OF BIRTH VS. HELICOPTER TRANSFER TO ANOTHER HOSPITAL

    May 1, 2019, 00:00

  • PDB56 COSTS ASSOCIATED WITH INITIATING EMPAGLIFLOZIN VERSUS OTHER ANTIHYPERGLYCEMIC AGENTS IN PATIENTS WITH TYPE 2 DIABETES AND CARDIOVASCULAR DISEASE: A RETROSPECTIVE COHORT STUDY

    May 1, 2019, 00:00

  • PMU37 ASSOCIATION OF OSTEOARTHRITIS AND PAIN WITH ALZHEIMER'S DISEASES AND RELATED DEMENTIAS AMONG OLDER ADULTS IN THE UNITED STATES

    May 1, 2019, 00:00

  • PNS167 A REVIEW OF EVALUATION CRITERIA AND STRATEGIES FOR INSURANCE COVERAGE OF PERSONALIZED MEDICINE: U.S. PAYER PERSPECTIVES

    May 1, 2019, 00:00

  • Multiple Diseases - Epidemiology Public Health

    May 1, 2019, 00:00

  • PIH23 BUDGET IMPACT ANALYSIS OF SFLT-1/PLGF RATIO TO HELP RULE-OUT PRE-ECLAPMSIA IN WOMEN PRESENTING WITH SUSPECTED PRE-ECLAMPSIA IN THE PRIVATE HEALTHCARE SYSTEM IN BRAZIL

    May 1, 2019, 00:00

  • PCN260 THE CONTRIBUTION OF FUNCTION-RELATED INDICATORS (FRI) IN IDENTIFYING AND MODELING PATIENT COMPLEXITY

    May 1, 2019, 00:00

  • PNS85 MARKET ACCESS TRENDS ACROSS THE EU5 AND US: 2009 TO 2018- AN UPDATE

    May 1, 2019, 00:00

  • Diabetes/Endocrine/Metabolic Disorders - Clinical Outcomes

    May 1, 2019, 00:00

  • PDG82 IMPACT OF STATIN ADHERENCE ON CLINICAL OUTCOMES IN NEWLY TREATED PATIENTS FOR PRIMARY AND SECONDARY PREVENTION: A RETROSPECTIVE STUDY BASED ON CLAIMS DATABASE IN CHINA

    May 1, 2019, 00:00

  • PGI13 MEDICATION USE AND HEALTHCARE RESOURCE UTILIZATION TRENDS AMONG ADULT ULCERATIVE COLITIS PATIENTS IN THE UNITED STATES: 2007-2017

    May 1, 2019, 00:00

  • PMU5 ASSESSMENT OF COMMUNITY PHARMACY PROFESSIONALS’ KNOWLEDGE AND COUNSELING SKILLS ACHIEVEMENT TOWARDS HEADACHE MANAGEMENT: A CROSS-SECTIONAL AND SIMULATED-CLIENT BASED MIXED STUDY

    May 1, 2019, 00:00

  • PND91 PREDICTORS OF NON-ADHERENCE AMONG PATIENTS WITH MULTIPLE SCLEROSIS NEWLY INITIATING ONCE- OR TWICE-DAILY ORAL DISEASE-MODIFYING DRUGS

    May 1, 2019, 00:00

  • PNS190 PROPOSED MODELLING FRAMEWORK TO ASSESS THE VALUE OF A TREATMENT'S SAFETY PROFILE

    May 1, 2019, 00:00

  • PDB59 LIXISENATIDE, BASAL INSULIN AND PREMIXED INSULIN FOR THE TREATMENT OF PATIENTS WITH TYPE 2 DIABETES MELLITUS INADEQUATELY CONTROLLED BY ORAL ANTIDIABETIC DRUGS: NETWORK META-ANALYSIS AND COST-EFFECTIVENESS ANALYSIS

    May 1, 2019, 00:00

  • PND4 THE EFFECTIVENESS OF ANTIEPILEPTIC MEDICATIONS AS PROPHYLAXIS OF EARLY SEIZURE IN TRAUMATIC BRAIN INJURY PATIENTS COMPARED TO PLACEBO OR NO TREATMENT: A SYSTEMATIC REVIEW AND META-ANALYSIS

    May 1, 2019, 00:00

  • PIN53 PREDICTORS OF HUMAN PAPILLOMAVIRUS (HPV) VACCINE SERIES ADHERENCE AMONG CHILDREN, ADOLESCENTS, AND YOUNG ADULTS IN THE UNITED STATES DURING 2006-2016

    May 1, 2019, 00:00

  • PCN303 COMPARATIVE ANALYSIS OF PROFILES OF 65+ YEAR OLD STAGE IV PROSTATE CANCER PATIENTS BY TIME FROM DIAGNOSIS TO FIRST TREATMENT IN THE UNITED STATES

    May 1, 2019, 00:00

  • PND18 CLINICAL AND ECONOMIC IMPACT OF INITIATING DIMETHYL FUMARATE VERSUS OTHER DISEASE MODYFING THERAPIES IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS IN GERMANY

    May 1, 2019, 00:00

  • PND31 ECONOMIC EVALUATION OF ABOBOTULINUM TOXIN A VS ONABOTULINUM TOXIN A IN REAL-LIFE CLINICAL MANAGEMENT OF POST-STROKE UPPER LIMB SPASTICITY

    May 1, 2019, 00:00

  • PMU77 CELL AND GENE THERAPIES ARE ASSOCIATED WITH SUBSTANTIALLY LARGER QUALITY-ADJUSTED LIFE YEAR GAINS THAN CONVENTIONAL DRUGS AND BIOLOGICS

    May 1, 2019, 00:00

  • PCV58 COST-EFFECTIVENESS OF POPULATION-WIDE GENOMIC SCREENING FOR FAMILIAL HYPERCHOLESTEROLEMIA

    May 1, 2019, 00:00

  • PCN284 PSYCHOMETRIC EVALUATION AND SCORE INTERPRETATION OF THE NCCN-FACT OVARIAN SYMPTOM INDEX-18 IN PATIENTS WITH ADVANCED OVARIAN CANCER: REAL-WORLD EVIDENCE

    May 1, 2019, 00:00

  • PMH35 TREATMENT-SEEKING BEHAVIOR AMONG UNIVERSITY STUDENTS REPORTING PAIN AND DEPRESSION

    May 1, 2019, 00:00

  • PCV3 THROMBOPROPHYLAXIS OF VENOUS THROMBOEMBOLISM IN ACUTE MEDICALLY ILL PATIENTS: A NETWORK META-ANALYSIS

    May 1, 2019, 00:00

  • PND13 ESTIMATING STATE TRANSITIONS IN ALZHEIMER'S DISEASE BY AGE AND GENDER: ANALYSIS FROM A LONGITUDINAL COHORT

    May 1, 2019, 00:00

  • PIN50 ECONOMIC OUTCOMES OF PATIENTS WITH COMMUNITY-ACQUIRED PNEUMONIA (CAP) HOSPITALIZATIONS IN THE US: A RETROSPECTIVE COHORT STUDY, 2012-2017

    May 1, 2019, 00:00

  • PMH16 ECONOMIC BURDEN ASSOCIATED WITH NON-COMMUNICABLE DISEASES AMONG ADULTS WITH DEPRESSION AND ANXIETY IN THE UNITED STATES.

    May 1, 2019, 00:00

  • PNS225 A UNIFIED ANALYSIS AND MODELING FRAMEWORK FOR THE DESIGN OF OUTCOMES-BASED RISK-SHARING AGREEMENTS

    May 1, 2019, 00:00

  • PMD31 SWIPING RIGHT ON MEDICAL TECHNOLOGY; AN ANALYSIS OF DRUG VS. DEVICE HTA APPROVALS IN CANADA

    May 1, 2019, 00:00

  • PMU26 HEALTHCARE RESOURCE UTILIZATION AND CLINICAL OUTCOMES IN HOSPITALIZED PATIENTS WITH ALZHEIMER'S DISEASE AND RELATED DEMENTIAS IN THE UNITED STATES: A NATIONWIDE RETROSPECTIVE COHORT STUDY

    May 1, 2019, 00:00

  • PDB4 VARIATION IN THE ASSOCIATION BETWEEN METABOLIC SYNDROME AND NON-ALCOHOLIC FATTY LIVER DISEASE BY RACE

    May 1, 2019, 00:00

  • Infectious Diseases - Economic Evaluation

    May 1, 2019, 00:00

  • PGI5 LONG TERM ECONOMIC VALUE OF TIGHT CONTROL WITH ADALIMUMAB-BASED TREATMENT IN CROHN'S DISEASE: THE BRAZILIAN PUBLIC HEALTHCARE SYSTEM PERSPECTIVE

    May 1, 2019, 00:00

  • PIT18 INCREASING BURDEN OF MAJOR TRAUMA IN TAIWAN: TIME TREND OF INCIDENCE RATE AND LIFE EXPECTANCY LOSS

    May 1, 2019, 00:00

  • PCV16 MANAGEMENT OF GASTROINTESTINAL AND UROGENITAL BLEEDING EVENTS IN PATIENTS WITH NON VALVULAR ATRIAL FIBRILLATION TREATED WITH DABIGATRAN ETEXILATE EARLY AFTER APPROVAL

    May 1, 2019, 00:00

  • R You Still Using Excel? The Advantages of Modern Software Tools for Health Technology Assessment

    May 1, 2019, 00:00

  • PNS202 THE DEVELOPMENT OF A HEALTH ECONOMIC MODEL MARKUP LANGUAGE AS A FOUNDATION FOR MODEL TRANSPARENCY

    May 1, 2019, 00:00

  • PIH8 NOVEL MEASUREMENT STRATEGIES FOR COLLECTION OF CLINICAL OUTCOME ASSESSMENTS IN A PEDIATRIC POPULATION

    May 1, 2019, 00:00

  • PMD20 CENTRIFUGAL VERSUS MEMBRANE THERAPEUTIC PLASMA EXCHANGE: SINGLE CENTER COST BENEFIT ANALYSIS IN THAILAND

    May 1, 2019, 00:00

  • PMU53 ASSESSMENT OF THE ROUTES OF PATIENTS IN HUNGARIAN ONE-DAY SURGERY

    May 1, 2019, 00:00

  • PNS236 RAPID WEIGHT GAIN AND HEALTH-RELATED QUALITY OF LIFE: RESULTS FROM LINKING ELECTRONIC HEALTH RECORDS TO PATIENT-REPORTED OUTCOMES

    May 1, 2019, 00:00

  • Infectious Diseases - Epidemiology Public Health

    May 1, 2019, 00:00

  • Injury Trauma - Economic Evaluation

    May 1, 2019, 00:00

  • PNS227 STRESS AND ITS ASSOCIATION WITH ADVANCED PHARMACY PRACTICE EXPERIENCES AMONG PHARMACY STUDENTS

    May 1, 2019, 00:00

  • PIN100 IMPACT OF CHRONIC HEPATITIS B VIRUS INFECTION ON HEALTH-RELATED QUALITY OF LIFE: A LITERATURE REVIEW

    May 1, 2019, 00:00

  • Neurological Disorders - Real World Data Information Systems

    May 1, 2019, 00:00

  • PDB61 COMPARE LIXISENATIDE WITH RAPID-ACTING INSULIN INTENSIFICATION REGIMENS ON TOP OF BASAL INSULIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: A COST PER RESPONDER AND NUMBER NEEDED TO TREAT ANALYSIS IN CHINA

    May 1, 2019, 00:00

  • Musculoskeletal Disorders - Health Policy Regulatory

    May 1, 2019, 00:00

  • PND38 EVALUATION OF DEMENTIA INFORMAL CAREGIVERS WILLINGNESS TO PAY FOR A NONPHARMACOLOGIC INTERVENTION TO REDUCE BEHAVIORAL SYMPTOMS

    May 1, 2019, 00:00

  • PIH52 DEMENTIA-RELATED PSYCHOSIS: REAL-WORLD PATIENT CHARACTERISTICS AND HEALTHCARE UTILIZATION FROM A LARGE US ADMINISTRATIVE CLAIMS DATABASE

    May 1, 2019, 00:00

  • PMH56 PATIENT REPORTED OUTCOMES (PRO) COLLECTED AS PART OF THE CLINICAL PROCESS: THE CHALLENGE OF ADMINISTERING, SCORING, STORING, AND INTERPRETING PHQ-9 SCORES BEYOND THE CLINICAL MOMENT

    May 1, 2019, 00:00

  • Diabetes/Endocrine/Metabolic Disorders - Health Policy Regulatory

    May 1, 2019, 00:00

  • PIN69 RACIAL DISPARITIES IN RECORDING ANTIMICROBIAL RESISTANCE AMONG OLDER PEOPLE WITH URINARY TRACT INFECTIONS

    May 1, 2019, 00:00

  • Multivariable and Structural Uncertainty Analyses for Cost-Effectiveness Estimates: Back to the Future

    May 1, 2019, 00:00

  • PNS183 WHAT METHODS ARE APPLIED IN ASSESSESSING THE CLINICAL AND COST EFFECTIVENESS OF HEALTH TECHNOLOGIES BASED ON THE USE OF SURROGATE OUTCOMES: A COMPARISON OF EVALUATION REPORTS ACROSS INTERNATIONAL HEALTH TECHNOLOGY ASSESSMENT AGENCIES ...

    May 1, 2019, 00:00

  • PMU43 DISEASE PRIORITISATION MCDA MODEL FOR INFORMING HEALTHCARE PRIORITIES SETTING IN UKRAINE

    May 1, 2019, 00:00

  • Individual's Health - Economic Evaluation

    May 1, 2019, 00:00

  • PDG44 DRUG INFORMATION ON THE INTERNET - CONSISTENTLY INCONSISTENT RESULTS: CONTENT ANALYSIS USING THREE MAJOR SEARCH ENGINES

    May 1, 2019, 00:00

  • PND33 FINANCIAL ACCESS TO AND RACIAL/ETHNIC DISPARITIES IN HEALTHCARE UTILIZATION AMONG PATIENTS WITH DEMENTIA

    May 1, 2019, 00:00

  • PCN233 SOCIETAL BURDEN OF BREAST CANCER: IMPACT ON THE BRAZILIAN SOCIAL SECURITY SYSTEM

    May 1, 2019, 00:00

  • PCV25 DISEASE BURDEN OF HEART FAILURE IN A DEVELOPING COUNTRY

    May 1, 2019, 00:00

  • PCV105 EXAMINING THRESHOLDS FOR THE RENIN-ANGIOTENSIN SYSTEM ANTAGONIST MEDICATION ADHERENCE QUALITY MEASURE: THE APPLICATION OF THE LAW OF DIMINISHING RETURNS TO OPTIMIZE ADHERENCE-ASSOCIATED ECONOMIC OUTCOMES

    May 1, 2019, 00:00

  • PIN99 DETAILED INSIGHT FROM ELECTRONIC HEALTH RELATED QUALITY OF LIFE DATA IN HIV FOR PAYER DECISION MAKING — A WAY TO BETTER ALLOCATE RESOURCES AND SUPPORT PATIENTS

    May 1, 2019, 00:00

  • PNS250 USING TOOLS OF BEHAVIORAL SCIENCE TO IMPROVE PATIENT ENGAGEMENT, RETENTION AND ADHERENCE

    May 1, 2019, 00:00

  • Multiple Diseases - Medical Technologies

    May 1, 2019, 00:00

  • PCV29 HOSPITAL BUDGET IMPACT OF SWITCHING TO AN ALTERNATIVE ASPIRIN FORMULATION WITH IMPROVED GI SAFETY FOR TREATMENT OF ACUTE CARDIOVASCULAR EVENTS

    May 1, 2019, 00:00

  • Cardiovascular Disorders - Patient-Centered Research

    May 1, 2019, 00:00

  • PDB105 HEMOGLOBIN A1C (HBA1C) TESTING FREQUENCY AND HEALTH-RELATED QUALITY OF LIFE (HRQOL) IN PATIENTS WITH TYPE 2 DIABETES: AN ELECTRONIC HEALTH RECORDS LINKED WITH PATIENT-REPORTED OUTCOMES STUDY

    May 1, 2019, 00:00

  • PMS12 TOCILIZUMAB IN MODERATE-TO-SEVERE RHEUMATOID ARTHRITIS: SYSTEMATIC REVIEW OF EFFICACY AND SAFETY

    May 1, 2019, 00:00

  • PDB33 USING REAL WORLD DATA TO ESTIMATE THE POTENTIAL IMPACT OF TYPE 2 DIABETES RELATED COMPLICATIONS IN DIABETIC PATIENTS FROM THE PERSPECTIVE OF PUBLIC HEALTH SYSTEM IN CHILE.

    May 1, 2019, 00:00

  • PIN42 THE IMPACT OF DIGITAL MEDICINE PROGRAM ON ECONOMIC AND PUBLIC HEALTH BENEFITS FOR HCV COVERAGE EXPANSION FROM A STATE MEDICAID PERSPECTIVE

    May 1, 2019, 00:00

  • PND27 ECONOMIC BURDEN OF PROBABLE LENNOX-GASTAUT SYNDROME, PROBABLE DRAVET SYNDROME, AND OTHER REFRACTORY EPILEPSIES FOR UNITED STATES COMMERCIAL HEALTH PLANS

    May 1, 2019, 00:00

  • PNS175 A DESCRIPTIVE ANALYSIS OF ICER ACCEPTANCE OF PHARMACEUTICAL MANUFACTURERS COMMENTS

    May 1, 2019, 00:00

  • PIN90 HEALTH-ECONOMIC MODELLING TO INFORM PRIVATE SECTOR INVESTMENT IN INFECTIOUS DISEASE TREATMENTS IN MIDDLE-INCOME COUNTRIES: THE CASE OF TUBERCULOSIS

    May 1, 2019, 00:00

  • PCV4 REAL WORLD EVIDENCE OF RECURRENT VENUS THROMBOEMBOLISM (RVTE) IN ELDERLY PATIENTS: DIFFERENCES BY PHARMACOLOGIC PROPHYLAXIS TREATMENT

    May 1, 2019, 00:00

  • NO Specific Disease - Patient-Centered Research

    May 1, 2019, 00:00

  • PNS66 EQ-5D DERIVED POPULATION NORMS OF GENERAL POPULATION OF AZAD JAMMU AND KASHMIR (AJK) BY DEMOGRAPHIC CHARACTERISTICS

    May 1, 2019, 00:00

  • PNS122 REGULATORY BASIS FOR THE ORGANIZATION OF RISK-SHARING SCHEMES IN THE RUSSIAN FEDERATION

    May 1, 2019, 00:00

  • PDB8 USING REAL WORLD DATA (RWD) TO IDENTIFY SUBPOPULATIONS OF NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND ASSOCIATIONS WITH CARDIOVASCULAR (CV) AND LIVER-RELATED OUTCOMES

    May 1, 2019, 00:00

  • PDB96 BUDGET IMPACT MODELLING OF POINT-OF-CARE HBA1C MONITORING OF PATIENTS WITH DIABETES MELLITUS TYPE II IN MID-INCOME COUNTRIES

    May 1, 2019, 00:00

  • PDB120 UNDERSTANDING PATIENTS' WILLINGNESS TO PAY (WTP) FOR BIPHASIC INSULIN ASPART 30/70 (BIASP30) IN A FLEXPEN® DEVICE OR USING A PENFILL® FOR TYPE 2 DIABETES (T2D) TREATMENT IN AN OUT-OF-POCKET PAYMENTS MARKET

    May 1, 2019, 00:00

  • PMD45 PAIN RELIEF AND FUNCTION RESTORATION AFTER PRIMARY TOTAL KNEE ARTHROPLASTY: AN EVALUATION USING KNEE INJURY AND OSTEOARTHRITIS OUTCOME SCORE IN REAL WORLD DATA

    May 1, 2019, 00:00

  • PNS53 ADHERENCE OF 2017-PUBLISHED COST-EFFECTIVENESS ANALYSIS (CEA) ARTICLES TO METHODOLOGICAL STANDARDS FOR INCREMENTAL COST-EFFECTIVENESS RATIOS (ICERS) AND OTHER METHODS-ORIENTED QUALITY ATTRIBUTES

    May 1, 2019, 00:00

  • PMU91 USING HIGH POWERED ANALYTICS AND CUSTOMER RELATIONSHIP MANAGEMENT (CRM) TOOLS TO PROVIDE A BETTER MEMBER EXPERIENCE: BCBSLA MAKING A DIFFERENCE

    May 1, 2019, 00:00

  • PCV66 BASELINE CHARACTERISTICS AMONG VENTRICULAR TACHYCARDIA ABLATION PATIENTS: A MULTI-HOSPITAL DATABASE ANALYSIS

    May 1, 2019, 00:00

  • PDB106 QUALITY OF LIFE AND TREATMENT SATISFACTION IN PATIENTS WITH DIABETES AND CONTINUOUS SUBCUTANEOUS INSULIN PUMP / REAL TIME - CONTINUOUS GLUCOSE MONITORING

    May 1, 2019, 00:00

  • PCV78 RISK FACTORS FOR DECOMPENSATION AND CARDIOVASCULAR MORTALITY IN HEART FAILURE PATIENTS WITH REDUCED OR PRESERVED EJECTION FRACTION

    May 1, 2019, 00:00

  • PDG79 MULTIVARIATE NETWORK META-ANALYSIS MODELS THAT INCORPORATE MULTIPLE OUTCOMES CAN PRODUCE MORE ACCURATE COMPARATIVE EFFECTIVENESS ESTIMATES THAN STANDARD UNIVARIATE MODELS

    May 1, 2019, 00:00

  • PNS52 CAN COST-EFFECTIVENESS ANALYSIS INFORM THE EXTENT OF COVERAGE UNDER PUBLIC HEALTHCARE? A MICROSIMULATION MODEL OF ALTERNATIVE PRENATAL SCREENING AND DIAGNOSTIC STRATEGIES

    May 1, 2019, 00:00

  • PMD49 IMPACT OF SURGICEL ON SURGICAL OUTCOMES AND HOSPITAL COSTS ASSOCIATED WITH OPEN GASTRECTOMY IN A CHINESE TIER III TERTIARY CARE HOSPITAL

    May 1, 2019, 00:00

  • PMD29 HOSPITAL RELATED CLINICAL AND ECONOMICAL OUTCOMES OF A OXIDIZED ZIRCONIUM HIP SYSTEM IN TOTAL HIP ARTHROPLASTY PATIENTS

    May 1, 2019, 00:00

  • Mental Health - Real World Data Information Systems

    May 1, 2019, 00:00

  • PMU64 THE IMPACT OF FORMULARY RESTRICTIONS ON LIKELIHOOD OF SUCCESSFUL DISPENSATION OF ANTIEPILEPTIC DRUG TREATMENT IN A PEDIATRIC PATIENT POPULATION

    May 1, 2019, 00:00

  • PMS21 HOW EXPENSIVE IS TREATING PATIENTS IN A CENTER OF EXCELLENCE FOR RHEUMATOID ARTHRITIS IN COLOMBIA?

    May 1, 2019, 00:00

  • PMU6 ASSOCIATION OF POWERED STAPLING TECHNOLOGY WITH ECONOMIC AND CLINICAL OUTCOMES: EVIDENCE FROM REAL-WORLD ASSESSMENTS OF BARIATRIC, RIGHT COLORECTAL, AND THORACIC LOBECTOMY PROCEDURES CONDUCTED VIA MINIMALLY-INVASIVE APPROACHES

    May 1, 2019, 00:00

  • PCV12 COMPARATIVE EFFECTIVENESS AND SAFETY OF NON-VITAMIN K ANTAGONISTS VERSUS WARFARIN IN ELDERLY PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION AND DIABETES

    May 1, 2019, 00:00

  • PNS172 COMPARISON OF CURRENT AND PREFERRED STATUS OF HTA IMPLEMENTATION IN JORDAN

    May 1, 2019, 00:00

  • Individual's Health - Epidemiology Public Health

    May 1, 2019, 00:00

  • Drugs Statistical Research

    May 1, 2019, 00:00

  • PMS22 CLINICAL AND COST EFFECTIVENESS OF PHYSIOTHERAPY INTERVENTIONS FOLLOWING TOTAL KNEE REPLACEMENT- A SYSTEMATIC REVIEW AND META-ANALYSIS

    May 1, 2019, 00:00

  • PIN60 LYME DISEASE FIRST-LINE TREATMENT AND PROGRESSION IN FLORIDA AND THE NORTHEASTERN US: A COMPARISON USING REAL-WORLD DATA

    May 1, 2019, 00:00

  • PIN18 COSTS OF ADULT VACCINATION IN MEDICAL SETTINGS AND PHARMACIES: AN OBSERVATIONAL STUDY

    May 1, 2019, 00:00

  • PDB35 CONTRASTING FRAMINGHAM RISK EQUATIONS IN TYPE 2 DIABETES USING THE IQVIA CORE DIABETES MODEL

    May 1, 2019, 00:00

  • PCN232 DIVERGENT HTA DECISIONS IN EUROPE FOR ONCOLOGY DRUGS GRANTED BREAKTHROUGH DESIGNATION

    May 1, 2019, 00:00

  • PDG40 PRESCRIPTION OPIOID MEDICATION EXPOSURE AMONG MEDICARE BENEFICIARIES

    May 1, 2019, 00:00

  • PDB65 NON-ALCOHOLIC STEATOHEPATITIS (NASH): US PAYER VALUE AND COVERAGE OF POTENTIAL NASH THERAPIES

    May 1, 2019, 00:00

  • PNS266 LANDSCAPE ANALYSIS OF IMPACT OF MACHINE LEARNING, NATURAL LANGUAGE PROCESSING, ARTIFICIAL INTELLIGENCE AND BLOCKCHAIN TECHNOLOGY ON LEVERAGING REAL WORLD EVIDENCE (RWE)

    May 1, 2019, 00:00

  • PMS3 A LOW-COST MODEL OF ADHERENCE/ATTENDANCE OF PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING BIOLOGICAL THERAPY IN A SPECIALIZED CENTER

    May 1, 2019, 00:00

  • PCV110 DEMOGRAPHIC AND CLINICAL PROFILES OF VERY-HIGH-RISK ATHEROSCLEROSIS PATIENTS AND ITS RELATED TREATMENT PATTERNS IN CHINA: A REAL-WORLD ELECTRONIC MEDICAL RECORDS DATABASE ANALYSIS

    May 1, 2019, 00:00

  • PIH43 ASSOCIATION OF SLEEP QUALITY TO TELOMERE LENGTH, A MARKER OF CELLULAR AGING. A RETROSPECTIVE COHORT STUDY OF OLDER ADULTS IN THE UNITED STATES

    May 1, 2019, 00:00

  • PND64 TRENDS AND DISPARITIES IN PHARMACEUTICAL TREATMENT FOR ALZHEIMER’S DISEASE AND RELATED DEMENTIA PATIENTS

    May 1, 2019, 00:00

  • PMD46 UNDERSTANDING DISCRETE CHOICE PREFERENCES FOR A NOVEL PROSTHETIC DEVICE IN PERSONS WITH LOWER LIMB LOSS

    May 1, 2019, 00:00

  • PNS117 PATIENT, PAYER AND MANUFACTURER PERSPECTIVES ON FOUR COST-CONTROL MECHANISMS FOR PHARMACEUTICALS

    May 1, 2019, 00:00

  • PMH29 OPIOID USE AMONG INDIVIDUALS WITH DEPRESSION:NHAES STUDY 2005-2014

    May 1, 2019, 00:00

  • PCV59 ESTIMATING ECONOMIC AND HEALTH OUTCOMES ASSOCIATED WITH ADHERENCE TO TREATMENT FOR HYPERTENSION

    May 1, 2019, 00:00

  • PNS243 REVIEW OF PATIENT REPORTED OUTCOME (PRO) MEASURES FOR NOVEL DRUG APPROVALS (NDA) IN THE UNITED STATES: 2016-2018

    May 1, 2019, 00:00

  • Musculoskeletal Disorders - Clinical Outcomes

    May 1, 2019, 00:00

  • PIH68 DO PATIENT CONCERNS ABOUT ANTIHYPERTENSIVE USE AS A DEMENTIA PREVENTION STRATEGY VARY BY CURRENT USE OF ANTIHYPERTENSIVE MEDICATION?

    May 1, 2019, 00:00

  • PGI8 BUDGET IMPACT ANALYSIS OF LINX REFLUX MANAGEMENT SYSTEM FOR THE TREATMENT OF MEDICATION-REFRACTORY MECHANICAL GASTROESOPHAGEAL REFLUX DISEASE: A U.S. PAYER PERSPECTIVE

    May 1, 2019, 00:00

  • PND41 HEALTHCARE EXPENDITURE BURDEN IN MULTIPLE SCLEROSIS: MARGINAL COSTS BASED ON NATIONAL LEVEL DATA

    May 1, 2019, 00:00

  • PND51 PATTERNS OF ANTIDEMENTIAL DRUG USE IN A GROUP OF PATIENTS FROM COLOMBIA

    May 1, 2019, 00:00

  • PNS140 PHARMACY PATRONAGE: ASSESSING HOW RESPONDENTS SELECT THEIR PHARMACY USING THE DETERMINANT ATTRIBUTE APPROACH

    May 1, 2019, 00:00

  • PIH44 IMPACTS OF THE ENVIRONMENTAL POLICY ON INFANT MORTALITY IN THE UNITED STATES

    May 1, 2019, 00:00

  • PCV51 A MICROCOSTING STUDY FOR ANGIOPLASTY PROCEDURE: REAL WORLD DATA IN SOUTHERN BRAZIL

    May 1, 2019, 00:00

  • PCN285 KNOWLEDGE AND AWARENESS OF MISMATCH REPAIR/MICROSATELLITE INSTABILITY (MMR/MSI) TESTING AMONG US PATIENTS WITH ADVANCED/METASTATIC COLORECTAL CANCER (MCRC)

    May 1, 2019, 00:00

  • PNS148 EDUCATING PUBLIC ABOUT DISABILITY AND GIVING PEOPLE WITH DISABILITY THE SAME OPPORTUNITY AS PEOPLE WITHOUT DISABILITY: DESCRIPTIVE ANALYSIS.

    May 1, 2019, 00:00

  • PMH45 PREDICTORS OF ANTIMUSCARNIC MEDICATION USE AMONG ELDERLY DEMENTIA PATIENTS WITH OVERACTIVE BLADDER: A RETROSPECTIVE STUDY OF MEDICARE BENEFICIARIES

    May 1, 2019, 00:00

  • PNS89 INTERNATIONAL COMPARISON OF THE REMUNERATION OF PHYSICIANS AMONG COUNTRIES WITH BISMARCK AND BEVERIDGE HEALTH CARE SYSTEM

    May 1, 2019, 00:00

  • Mental Health - Medical Technologies

    May 1, 2019, 00:00

  • PNS96 NICE SOCIAL MEDIA - IMPACT OF AD-HOC PUBLIC COMMENTS ON HST RECOMMENDATIONS

    May 1, 2019, 00:00

  • PMH27 RELATIONSHIP BETWEEN DISENGAGEMENT BELIEFS, PERCEIVED RISKS-BENEFITS, SMOKING SELF-EFFICACY AND MOTIVATION TO QUIT SMOKING AMONG ADULT SMOKERS

    May 1, 2019, 00:00

  • Cardiovascular Disorders - Economic Evaluation

    May 1, 2019, 00:00

  • PIN49 EXAMINING THE CLINICAL AND ECONOMIC IMPACT OF ANTIMICROBIAL RESISTANCE AT ACUTE CARE FACILITIES: A PRACTICAL TOOL

    May 1, 2019, 00:00

  • PCV54 COST-EFFECTIVENESS OF ASPIRIN FOR PRIMARY PREVENTION OF CARDIOVASCULAR EVENTS IN CHINESE PATIENTS WITH DIABETES

    May 1, 2019, 00:00

  • PDB58 GESTATIONAL DIABETES SCREENING IN CHINA: A COST-EFFECTIVENESS STUDY

    May 1, 2019, 00:00

  • Multiple Diseases - Methodological Statistical Research

    May 1, 2019, 00:00

  • PMH12 COST-EFFECTIVENESS OF PALIPERIDONE PALMITATE 3-MONTH VERSUS 1-MONTH FOR THE TREATMENT OF SCHIZOPHRENIA IN THE UNITED STATES

    May 1, 2019, 00:00

  • PDB7 DIABETIC COMPLICATIONS ASSOCIATED WITH SGLT2 AND DPP4 INHIBITORS: A REAL-WORLD APPROACH

    May 1, 2019, 00:00

  • Infectious Diseases - Real World Data Information Systems

    May 1, 2019, 00:00

  • Individual's Health - Health Policy Regulatory

    May 1, 2019, 00:00

  • PNS255 PATIENTS RELATED ISSUES ARISING FROM REGULATORY APPROVAL, PRICING AND LAUNCH PLAN OF PHARMACEUTICAL PRODUCTS

    May 1, 2019, 00:00

  • PCV88 REAL-WORLD STUDY OF TREATMENT INTENSIFICATION OF STATINS IN PATIENTS WITH UNCONTROLLED ATHEROSCLEROTIC CARDIOVASCULAR DISEASE (ASCVD)

    May 1, 2019, 00:00

  • PIN85 GLOBAL COMPLIANCE WITH HEPATITIS B VACCINE BIRTH DOSE AND FACTORS RELATED TO TIMELY SCHEDULE. A LITERATURE REVIEW

    May 1, 2019, 00:00

  • PMH20 THE ECONOMIC BURDEN OF BIPOLAR DISORDER IN THE UNITED STATES: RESULTS FROM A SYSTEMATIC LITERATURE REVIEW

    May 1, 2019, 00:00

  • PMS47 SEXUAL FUNCTION IN PSORIATIC ARTHRITIS: A PATIENT REPORTED OUTCOMES REVIEW

    May 1, 2019, 00:00

  • PMS31 IMPACT OF OPIOID DOSE ESCALATION ON THE DEVELOPMENT OF SUBSTANCE USE DISORDERS, ACCIDENTS, SELF-INFLICTED INJURIES, OPIOID OVERDOSES, AND ALCOHOL AND NON-OPIOID DRUG-RELATED OVERDOSES: A RETROSPECTIVE COHORT STUDY

    May 1, 2019, 00:00

  • PGI3 INDIRECT TREATMENT COMPARISONS AND NETWORK META-ANALYSES OF NALDEMEDINE FOR THE TREATMENT OF OPIOID-INDUCED CONSTIPATION

    May 1, 2019, 00:00

  • PIH46 OPIOID PRESCRIPTION DRUG UTILIZATION IN CHILDREN AND ADOLESCENTS WITH ASTHMA

    May 1, 2019, 00:00

  • PND19 CLINICAL AND ECONOMIC IMPACT OF INITIATING DIMETHYL FUMARATE VERSUS GLATIRAMER ACETATE IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS IN EUROPE

    May 1, 2019, 00:00

  • PNS265 AUTOMATED DISCOVERY OF COMPARATIVE EFFECTIVENESS HYPOTHESES FROM MEDICAL LITERATURE.

    May 1, 2019, 00:00

  • PMH67 USING REAL WORLD DATA TO PROFILE CURRENT STANDARD OF CARE FOR SCHIZOPHRENIA PATIENTS AT A MENTAL HEALTH HOSPITAL IN RWANDA, AFRICA

    May 1, 2019, 00:00

  • PCN315 CHARACTERISTICS OF REGISTRY PUBLICATIONS IN HEMATOLOGY-ONCOLOGY JOURNALS AND ASSOCIATION WITH IMPACT FACTOR

    May 1, 2019, 00:00

  • PMH22 IS INCREASED SEVERITY STATUS ASSOCIATED WITH INCREMENTAL ECONOMIC BURDEN IN PRIVATELY INSURED US PATIENTS WITH TREATMENT RESISTANT DEPRESSION?

    May 1, 2019, 00:00

  • PMH18 THE IMPLEMENTATION OF COMPETING RISKS USING DIFFERENT MODELING TECHNIQUES AND STRUCTURES: THE EFFECT ON INCREMENTAL COST-EFFECTIVENESS

    May 1, 2019, 00:00

  • Neurological Disorders - Economic Evaluation

    May 1, 2019, 00:00

  • PMU7 ASSOCIATION OF ADVERSE CHILDHOOD EVENTS AND HEALTH OUTCOMES WITHIN THE BRFSS DATABASE IN PENNSYLVANIA

    May 1, 2019, 00:00

  • PDB119 CLINICAL USE OF FAST-ACTING INSULIN ASPART IN PEOPLE WITH TYPE 1 AND TYPE 2 DIABETES, A SURVEY OF PHYSICIANS' EXPERIENCES AND TREATMENT SATISFACTION

    May 1, 2019, 00:00

  • PIN63 CUMULATIVE COMPLETION RATES FOR HUMAN PAPILLOMAVIRUS VACCINE (HPV) AMONG CHILDREN, ADOLESCENTS, AND YOUNG ADULTS IN THE UNITED STATES DURING 2006-2016

    May 1, 2019, 00:00

  • PDB116 REAL-WORLD ADHERENCE AND PERSISTENCE AMONG ELDERLY PATIENTS WITH T2DM INITIATING DULAGLUTIDE VS. LIRAGLUTIDE OR EXENATIDE ONCE-WEEKLY IN THE US

    May 1, 2019, 00:00

  • PGI20 A REPORT ON THE QUALITY OF LIFE OF OSTOMATES IN THE NETHERLANDS

    May 1, 2019, 00:00

  • PMU24 BUDGET IMPACT OF SECUKINUMAB FOR THE TREATMENT OF MODERATE-TO-SEVERE PLAQUE PSORIASIS, PSORIATIC ARTHRITIS AND ANKYLOSING SPONDYLITIS FROM THE COLOMBIAN HEALTHCARE PERSPECTIVE

    May 1, 2019, 00:00

  • PDG71 ACCESS TO NALOXONE AND PREFERENCES REGARDING ONLINE PURCHASE OF NALOXONE AMONG INDIVIDUALS AFFECTED BY OPIOID ABUSE OR DEPENDENCE

    May 1, 2019, 00:00

  • PMH25 REAL-WORLD EVIDENCE INVESTIGATION ON HEALTHCARE UTILIZATION AND COST AMONG NEGATIVE SYMPTOM PATIENTS AND NON-NEGATIVE SYMPTOM PATIENTS WITH SCHIZOPHRENIA IN THE US

    May 1, 2019, 00:00

  • PIN81 FACTORS INFLUENCING MENINGOCOCCAL VACCINATION UPTAKE AMONG ADOLESCENTS IN THE UNITED STATES

    May 1, 2019, 00:00

  • PIN8 PROTEASE INHIBITOR EXPOSURE AND THE RISK OF DEVELOPING DIABETES MELLITUS IN TREATED HIV SEROPOSITIVE PATIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS

    May 1, 2019, 00:00

  • PCV46 A SYSTEMATIC LITERATURE REVIEW OF THE INDIRECT COSTS ASSOCIATED WITH STROKE, BLEEDING, AND VITAMIN K ANTAGONIST MONITORING IN ATRIAL FIBRILLATION

    May 1, 2019, 00:00

  • PCV9 UNMET NEEDS BURDEN OF RECURRENT PERICARDITIS (RP): RESULTS OF A SYSTEMATIC LITERATURE REVIEW (SLR)

    May 1, 2019, 00:00

  • PDG21 COST-EFFECTIVENESS OF JINGSHU GRANULES FOR THE TREATMENT OF PATIENTS WITH CERVICAL RADICULOPATHY IN CHINA: A DECISION-TREE MODEL BASED ON RANDOMIZED CONTROLLED TRIAL

    May 1, 2019, 00:00

  • PIT10 COST AND COST-EFFECTIVENESS IMPLICATIONS OF UTILIZING IMMEDIATE ACUTE MAGNETIC RESONANCE IMAGING IN THE MANAGEMENT OF PATIENTS WITH SUSPECTED SCAPHOID FRACTURE AND NEGATIVE INITIAL RADIOGRAPHS: RESULTS FROM A RANDOMIZED CLINICAL TRIAL ...

    May 1, 2019, 00:00

  • PDB127 A RETROSPECTIVE DATABASE ANALYSIS ASSESSING THE RELATIONSHIP BETWEEN PHARMACY QUALITY ALLIANCE-DEFINED ANTI-DIABETIC MEDICATION ADHERENCE AND DISEASE STATE CONTROL, HEALTHCARE UTILIZATION AND COSTS IN A MEDICARE SUPPLEMENTAL SAMPLE

    May 1, 2019, 00:00

  • PIN12 ASSESSING KNOWLEDGE ABOUT HAND HYGIENE IN A CITY HOSPITAL, HUNGARY

    May 1, 2019, 00:00

  • PIN75 BABESIOSIS OCCURRENCE AMONG THE ELDERLY IN THE UNITED STATES: OVERALL, BY STATE, AND COUNTY OF RESIDENCE, AS RECORDED IN LARGE MEDICARE DATABASES DURING 2006-2017

    May 1, 2019, 00:00

  • PCV40 HEALTHCARE RESOURCE UTILIZATION AND COSTS ASSOCIATED WITH ABNORMAL POTASSIUM LEVELS AMONG US PATIENTS WITH SYSTOLIC AND DIASTOLIC HEART FAILURE: A POPULATION-BASED COHORT STUDY

    May 1, 2019, 00:00

  • PMU35 ECONOMIC BURDEN OF AIR POLLUTION IN COLOMBIA

    May 1, 2019, 00:00

  • PND47 ANNUAL PRESCRIPTION STIMULANT FILL TRENDS: AN ANALYSIS OF 17 STATES UTILIZING MEDICAID CLAIMS DATA

    May 1, 2019, 00:00

  • PMU20 CONSTRAINED OPTIMIZATION FOR IDENTIFYING THE COMBINATION OF PNEUMOCOCCAL VACCINATION SCHEMES WHICH MAXIMIZES QALY-GAINS OVER THE NEXT 10 YEARS IN BRAZIL

    May 1, 2019, 00:00

  • Personalized Information Systems

    May 1, 2019, 00:00

  • Diabetes/Endocrine/Metabolic Disorders - Epidemiology Public Health

    May 1, 2019, 00:00

  • PDG47 PRESCRIPTION PATTERNS AND INDICATIONS OF FLUOROQUINOLONES IN A GROUP OF AMBULATORY PATIENTS IN COLOMBIA, 2018

    May 1, 2019, 00:00

  • PDG49 UNINTENTIONAL AND SUICIDAL OPIOID OVERDOSE IN MEDICARE BENEFICIARIES

    May 1, 2019, 00:00

  • PND63 IMPACT OF ORAL DISEASE MODIFYING MEDICATION UTILIZATION ON MULTIPLE SLCEROSIS TREATMENT LANDSCAPE: TRENDS OVER THE PAST DECADE

    May 1, 2019, 00:00

  • PIN31 DOLUTEGRAVIR PLUS LAMIVUDINE FOR THE TREATMENT OF ART NAIVE ADULTS LIVING WITH HUMAN IMMUNODEFICIENCY VIRUS (HIV): A US COST-UTILITY ANALYSIS

    May 1, 2019, 00:00

  • PDB112 LITERATURE REVIEW OF PATIENT-REPORTED OUTCOMES (PRO) ASSOCIATED WITH MULTIPLE DAILY INSULIN INJECTION (MDI) THERAPY FOR PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM)

    May 1, 2019, 00:00

  • PNS155 VALUE-BASED CONTRACTING: DO PERSPECTIVES DIFFER BY PAYER TYPE?

    May 1, 2019, 00:00

  • PDG16 PREDICTING THE COST-EFFECTIVENESS OF GENERIC VERSUS BRAND DABIGATRAN USING PHARMACOMETRIC ESTIMATES AMONG PATIENTS WITH ATRIAL FIBRILLATION

    May 1, 2019, 00:00

  • PMH37 CLINICAL AND MEDICATION USE CHARACTERISTICS OF A US NATIONAL COHORT OF OLDER DEMENTIA PATIENTS

    May 1, 2019, 00:00

  • PCV56 COST- EFFECTIVENSS ANALYSIS OF COMBINING TRANDITIONAL CHINESE MEDICINE IN THE TREATMENT OF HYPERTENSION

    May 1, 2019, 00:00

  • PDB107 EVALUATING THE CONTENT VALIDITY OF THE PROMIS® PHYSICAL FUNCTION SHORT FORMS IN OVERWEIGHT AND OBESE INDIVIDUALS

    May 1, 2019, 00:00

  • Multiple Diseases - Health Policy Regulatory

    May 1, 2019, 00:00

  • PMU80 A SYSTEMATIC REVIEW OF ICER EVALUATIONS FROM 2008 TO 2018: RECENT TRENDS IN EVALUATION PROCESS AND LESSONS LEARNED

    May 1, 2019, 00:00

  • PNS228 HEOR AND RWE SOURCING AND PROCUREMENT CHALLENGES AND OPPORTUNITIES: A BENCHMARKING SURVEY

    May 1, 2019, 00:00

  • Medical Devices - Health Technology Assessment

    May 1, 2019, 00:00

  • PIN6 RELATIONSHIP BETWEEN PHARMACOLOGICAL NON-ADHERENCE AND VIROLOGICAL SUCCESS IN PATIENTS WITH HIV, COLOMBIA

    May 1, 2019, 00:00
  • «
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58 (current)
  • 59
  • 60
  • »